NM_178499.5:c.272A>G

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_178499.5(CCDC60):​c.272A>G​(p.Glu91Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)

Consequence

CCDC60
NM_178499.5 missense

Scores

1
8
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.17

Publications

0 publications found
Variant links:
Genes affected
CCDC60 (HGNC:28610): (coiled-coil domain containing 60)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC60NM_178499.5 linkc.272A>G p.Glu91Gly missense_variant Exon 3 of 14 ENST00000327554.3 NP_848594.2 Q8IWA6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC60ENST00000327554.3 linkc.272A>G p.Glu91Gly missense_variant Exon 3 of 14 1 NM_178499.5 ENSP00000333374.2 Q8IWA6

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 17, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.272A>G (p.E91G) alteration is located in exon 3 (coding exon 3) of the CCDC60 gene. This alteration results from a A to G substitution at nucleotide position 272, causing the glutamic acid (E) at amino acid position 91 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.093
T
BayesDel_noAF
Benign
-0.37
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.052
T
Eigen
Uncertain
0.46
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.045
D
MetaRNN
Uncertain
0.49
T
MetaSVM
Benign
-0.82
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
4.2
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-3.9
D
REVEL
Benign
0.17
Sift
Uncertain
0.0090
D
Sift4G
Uncertain
0.0050
D
Polyphen
1.0
D
Vest4
0.51
MutPred
0.17
Gain of MoRF binding (P = 0.0357);
MVP
0.55
MPC
0.41
ClinPred
0.97
D
GERP RS
5.2
Varity_R
0.23
gMVP
0.33
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr12-119909900; API